High-dose melphalan followed by autologous stem cell transplantation is currently the treatment of choice in fit patients affected by AL amyloidosis. However, the majority of AL amyloidos...
No takes yet. Share an insight, caveat, or question.
Moscetti et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: